Impact of prophylactic intra-aortic balloon pump on early outcomes in patients with severe left ventricular dysfunction undergoing elective coronary artery bypass grafting with cardiopulmonary bypass

https://doi.org/10.1016/j.ijcard.2023.05.033Get rights and content
Under a Creative Commons license
open access

Highlights

  • Prophylactic IABP in patients with reduced LVEF ≤ 30% is associated with reduced postoperative low cardiac output syndrome;

  • It was paralleled by reduced need for vasoactive and inotropic medications after the surgery;

  • Preoperative insertion of an IABP was not associated with lower in-hospital mortality;

  • Advanced age and cardiopulmonary bypass duration were independent risk factors for low output syndrome;

  • No IABP-related complications were observed

Abstract

Objective

Our aim was to analyse whether prophylactic preoperative intraaortic balloon pump (IABP) improves outcomes in hemodynamically stable patients with low left ventricular ejection fraction (LVEF ≤30%) undergoing elective myocardial revascularization (CABG) using cardiopulmonary bypass (CPB). Secondary aim was to identify the predictors for low cardiac output syndrome (LCOS).

Methods

Prospectively collected data of 207 consecutive patients with LVEF ≤30% undergoing elective isolated CABG with CPB from 01/2009 to 12/2019, 136 with and 71 patients without IABP, were retrieved retrospectively. Patients with prophylactic IABP were matched 1:1 with patients without IABP by a propensity score matching. Stepwise logistic regression was conducted to identify predictors of postoperative LCOS in the propensity-matched cohort. P value ≤0.05 was considered significant.

Results

Reduced postoperative LCOS (9.9% vs. 26.8%, P = 0.017) was observed in patients receiving prophylactic IABP. Stepwise logistic regression identified preoperative IABP as preventive factor for postoperative LCOS [Odds Ratio (OR) 0.19,95% Confidence Interval (CI), 0.06–0.55, P = 0.004]. The need of vasoactive and inotropic support was lower in patients with prophylactic IABP at 24, 48 and 72 h after surgery (12.3 [8.2–18.6] vs. 22.2 [14.4–28.8], P < 0.001, 7.7 [3.3–12.3] vs.16.3 [8.9–27.8], P < 0.001 and 2.4 [0–7] vs. 11.5 [3.1–26], P < 0.001, respectively). The patients in both groups did not differ in terms of in-hospital mortality (7.0% vs. 9.9%, P = 0.763). There were no major IABP-related complications.

Conclusions

Elective patients with left ventricular ejection fraction ≤30% undergoing CABG with CPB and prophylactic IABP insertion had less low cardiac output syndrome and similar in-hospital mortality.

Keywords

Coronary artery bypass grafting
Cardiopulmonary bypass
Reduced left ventricular ejection fraction
Prophylactic intra-aortic balloon pump
Low cardiac output syndrome

Abbreviations

APPT
Activated partial thromboplastin time
ACCT
Aortic cross clamping time
AKI
Acute kidney injury
AMI
Acute myocardial infarction
BMI
Body-Mass-Index
CABG
Coronary artery bypass grafting
CAD
Coronary artery disease
CCS
Canadian Cardiovascular Society
CI
Confidence interval
CO
Cardiac output
COPD
Chronic obstructive pulmonary disease
CPBT
Cardiopulmonary bypass time
CSA-AKI
Cardiac surgery-associated acute kidney injury
CVP
Central venous pressure
ECG
Electrocardiogram
IABP
Intra-aortic balloon pump
ICU
Intensive care unit
IQR
Interquartile range
LCOS
Low cardiac output syndrome
LV
Left ventricle
VF
Ventricular fibrillation
LVEF
Left ventricular ejection fraction
VT
Ventricular tachycardia
MAP
Mean arterial pressure
MPAP
Mean pulmonary arterial pressure
NYHA
New York Heart Association
OR
Odds-Ratio
PAC
Pulmonary artery catheter
PAOP
Pulmonary artery occluded pressure
PVR
Pulmonary vascular resistance
SCr
Serum creatinine
SaO2
Arterial oxygen saturation
SMD
Standard mean differences
SvcO2
Central venous oxygen saturation
SVR
Systemic vascular resistance
STS
The Society of Thoracic Surgeons
VA-ECMO
Veno-arterial Extracorporeal Membrane Oxygenation
VIS
Vasoactive-Inotropic Score
vs.
Versus

Cited by (0)

1

Dr. Kralev and Prof. Dr. Kalisnik have contributed equally to the paper and should be regarded as Co-first authors.

Presented at the 52th annual meeting of the Society for Thoracic-, Cardiac- and Vascular Surgery, 11th–14th February 2023 in Hamburg, Germany.